Lisa Stamp
#125,493
Most Influential Person Now
New Zealand rheumatologist
Lisa Stamp's AcademicInfluence.com Rankings
Lisa Stampphilosophy Degrees
Philosophy
#10262
World Rank
#14042
Historical Rank
Logic
#7164
World Rank
#8830
Historical Rank
Download Badge
Philosophy
Lisa Stamp's Degrees
- Bachelors Medicine University of Auckland
- Masters Rheumatology University of New Zealand
Why Is Lisa Stamp Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lisa Katrina Stamp is a New Zealand academic, and as of 2019 is a full professor at the University of Otago. Academic career After a 2003 PhD titled T lymphocyte cyclooxygenase isotypes and the role of T lymphocytes in modulating monocyte and synoviocyte cyclooxygenase expression at the University of Adelaide, Stamp moved to the University of Otago, rising to full professor.
Lisa Stamp's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Modulation of Genetic Associations with Serum Urate Levels by Body-Mass-Index in Humans (2015) (724)
- Mapping and predicting mortality from systemic sclerosis (2017) (328)
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. (2012) (258)
- Gout (2016) (253)
- Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. (2006) (224)
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. (2011) (212)
- Myeloperoxidase and oxidative stress in rheumatoid arthritis. (2012) (184)
- Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis (2007) (174)
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. (2008) (171)
- Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study (2015) (160)
- Allopurinol Dosing in Renal Impairment: Walking the Tightrope Between Adequate Urate Lowering and Adverse Events (2007) (151)
- Diet and rheumatoid arthritis: a review of the literature. (2005) (143)
- Allopurinol hypersensitivity: investigating the cause and minimizing the risk (2016) (129)
- Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. (2009) (127)
- A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. (2010) (124)
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update (2016) (114)
- Twenty-eight loci that influence serum urate levels: analysis of association with gout (2014) (111)
- Gout (2019) (109)
- The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. (2006) (102)
- Interleukin‐17: the missing link between T‐cell accumulation and effector cell actions in rheumatoid arthritis? (2004) (102)
- Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. (2009) (100)
- Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout (2013) (97)
- Hyperuricaemia and gout: time for a new staging system? (2014) (97)
- A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout (2017) (94)
- Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout (2015) (92)
- Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard (2017) (91)
- GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes (2016) (90)
- Gout and its comorbidities: implications for therapy. (2013) (84)
- Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10 (2011) (81)
- Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. (2010) (80)
- Wegener’s granulomatosis in New Zealand: evidence for a latitude‐dependent incidence gradient (2007) (80)
- Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis (2007) (79)
- ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches (2017) (77)
- Association of variation in Fcγ receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples (2010) (74)
- Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. (2013) (73)
- ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout (2016) (72)
- Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. (2007) (72)
- A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout (2007) (72)
- New Perspectives in Rheumatology: Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial and the Associated Food and Drug Administration Public Safety Alert (2018) (71)
- Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate (2010) (71)
- Native Joint Septic Arthritis: Epidemiology, Clinical Features, and Microbiological Causes in a New Zealand Population (2015) (67)
- Leflunomide-associated infections in rheumatoid arthritis. (2007) (67)
- Emerging therapies in the long‐term management of hyperuricaemia and gout (2007) (67)
- The renal urate transporter SLC17A1 locus: confirmation of association with gout (2012) (66)
- Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) (2017) (65)
- Effects of Changing from Oral to Subcutaneous Methotrexate on Red Blood Cell Methotrexate Polyglutamate Concentrations and Disease Activity in Patients with Rheumatoid Arthritis (2011) (63)
- A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation (2010) (60)
- Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis (2019) (59)
- Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout (2019) (59)
- Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout (2015) (57)
- The optimal use of allopurinol: an audit of allopurinol use in South Auckland. (2000) (56)
- The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion (2020) (55)
- The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics? (2006) (54)
- Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand (2018) (54)
- Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises (2016) (53)
- Monocyte Derived Interleukin (IL)-23 Is an Important Determinant of Synovial IL-17A Expression in Rheumatoid Arthritis (2009) (51)
- Brief Report: Validation of a Definition of Flare in Patients With Established Gout (2018) (51)
- Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis (2012) (50)
- Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action (2012) (50)
- Serum urate as a soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT validation criteria for soluble biomarkers. (2011) (50)
- Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis (2008) (49)
- Clinical Utility of Multi‐Energy Spectral Photon‐Counting Computed Tomography in Crystal Arthritis (2019) (49)
- Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout (2019) (49)
- The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity (2011) (47)
- Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study (2017) (47)
- Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin‐8 (CXCL8), Myeloid‐Related Protein 8/Myeloid‐Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease (2015) (46)
- Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. (2017) (45)
- IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis (2011) (44)
- Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects (2013) (44)
- COX‐2 inhibition and thrombotic tendency: a need for surveillance (2001) (44)
- Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout. (2014) (44)
- Performance of classification criteria for gout in early and established disease (2014) (43)
- Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases. (2011) (43)
- Relationship Between Serum Urate and Plasma Oxypurinol in the Management of Gout: Determination of Minimum Plasma Oxypurinol Concentration to Achieve a Target Serum Urate Level (2011) (43)
- The genetics of gout: towards personalised medicine? (2017) (42)
- Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual‐Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial (2019) (42)
- Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption (2013) (41)
- Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice. (2012) (41)
- Population‐Specific Resequencing Associates the ATP‐Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men (2017) (39)
- How to prevent allopurinol hypersensitivity reactions? (2018) (39)
- Development of a Dual‐Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout (2016) (39)
- Predicting allopurinol response in patients with gout. (2016) (38)
- The Challenges of Gout Management in the Elderly (2011) (38)
- Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout (2020) (36)
- Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance (2010) (36)
- The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets (2016) (35)
- Gout in renal transplant recipients (2006) (35)
- Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. (2008) (35)
- Gout in Solid Organ Transplantation (2012) (35)
- The Rheumatoid nodule: peripheral or central to rheumatoid arthritis? (2007) (34)
- Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. (2004) (34)
- Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study (2016) (33)
- ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis (2020) (33)
- Is There a Role for Consensus Guidelines for P. jiroveci Pneumonia Prophylaxis in Immunosuppressed Patients with Rheumatic Diseases? (2010) (33)
- Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate (2015) (33)
- Gout in solid organ transplantation: a challenging clinical problem. (2005) (33)
- Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand (2017) (32)
- Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout (2017) (32)
- Hydrogen sulfide acts as a pro‐inflammatory mediator in rheumatic disease (2017) (31)
- Hyperuricaemia and gout in New Zealand rural and urban Māori and non‐Māori communities (2013) (31)
- Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia. (2014) (31)
- Identifying Barriers to Smoking Cessation in Rheumatoid Arthritis (2015) (31)
- Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis (2008) (30)
- Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry. (2012) (29)
- Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard (2016) (29)
- Safety profile of anti-gout agents: an update (2014) (29)
- A biomarker of n−3 compliance in patients taking fish oil for rheumatoid arthritis (2003) (28)
- Allopurinol and kidney function: An update. (2016) (28)
- A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria (2013) (28)
- Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis (2018) (28)
- Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis. (2018) (27)
- Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank (2021) (27)
- Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout (2015) (26)
- Efficacy of a Rheumatoid Arthritis–Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial (2016) (26)
- Bilateral transient osteoporosis of the knee in pregnancy (2001) (25)
- The population pharmacokinetics of allopurinol and oxypurinol in patients with gout (2013) (25)
- Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares (2015) (25)
- Population-specific association between ABCG2 variants and tophaceous disease in people with gout (2017) (25)
- Serum Urate in Chronic Gout — Will It Be the First Validated Soluble Biomarker in Rheumatology? (2011) (24)
- Bringing It All Together: A Novel Approach to the Development of Response Criteria for Chronic Gout Clinical Trials (2011) (24)
- Patient Information about Gout: An International Review of Existing Educational Resources (2015) (24)
- Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus. (2020) (24)
- Tophus Measurement as an Outcome Measure for Clinical Trials of Chronic Gout: Progress and Research Priorities (2011) (23)
- Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity (2013) (23)
- Screening for hyperuricaemia and gout: a perspective and research agenda (2014) (23)
- Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated (2016) (22)
- Development of an ELISA-Based Competitive Binding Assay for the Analysis of Drug Concentration and Antidrug Antibody Levels in Patients Receiving Adalimumab or Infliximab (2016) (22)
- Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement. (2007) (21)
- Urate-Lowering Therapy: Current Options and Future Prospects for Elderly Patients with Gout (2014) (21)
- Audit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5‐year period (2007) (21)
- The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout (2014) (21)
- The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand (2016) (20)
- Therapeutic drug monitoring in rheumatic diseases: utile or futile? (2014) (20)
- An association of smoking with serum urate and gout: A health paradox. (2017) (20)
- Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank (2019) (19)
- Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event? (2010) (19)
- Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study (2019) (19)
- Molecular mechanism of an adverse drug-drug interaction of allopurinol and furosemide in gout treatment. (2014) (19)
- The relationship between ferritin and urate levels and risk of gout (2018) (19)
- The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial (2017) (19)
- Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout (2020) (19)
- Allopurinol hypersensitivity: Pathogenesis and prevention. (2020) (18)
- The PTPN22 Locus and Rheumatoid Arthritis: No Evidence for an Effect on Risk Independent of Arg620Trp (2010) (18)
- Expression of Methotrexate Transporters and Metabolizing Enzymes in Rheumatoid Synovial Tissue (2013) (18)
- HLA-B27 associated spondyloarthropathy and severe ascending aortitis. (2000) (17)
- A Population Pharmacokinetic Model for Low-Dose Methotrexate and its Polyglutamated Metabolites in Red Blood Cells (2013) (17)
- The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets (2009) (17)
- Renal dosing of allopurinol results in suboptimal gout care (2016) (16)
- Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities (2021) (16)
- Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women (2015) (16)
- The management of gout: Much has changed. (2016) (16)
- Digital-PCR for gene expression: impact from inherent tissue RNA degradation (2017) (16)
- Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples (2018) (16)
- Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20) (2014) (16)
- Comparison of the 2010 American College of Rheumatology/European League Against Rheumatism and the 1987 American Rheumatism Association Classification Criteria for Rheumatoid Arthritis in an Early Arthritis Cohort in New Zealand (2012) (16)
- Expert opinion on emerging urate-lowering therapies (2018) (16)
- Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. (2016) (15)
- Prevention and treatment of gout (2018) (15)
- Mediation analysis to understand genetic relationships between habitual coffee intake and gout (2018) (15)
- Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand (2015) (15)
- Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. (2020) (15)
- Assessing the Relationship Between Serum Urate and Urolithiasis Using Mendelian Randomization: An Analysis of the UK Biobank. (2021) (14)
- ABCG 2 polymorphisms in gout : insights into disease susceptibility and treatment approaches (2017) (14)
- Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets (2011) (14)
- Incidence of anti‐neutrophil cytoplasmic antibody‐associated vasculitis before and after the February 2011 Christchurch Earthquake (2017) (14)
- Individualising the dose of allopurinol in patients with gout (2017) (14)
- Lack of effect of tart cherry concentrate dose on serum urate in people with gout. (2019) (13)
- Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database (2020) (13)
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline (2022) (13)
- Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout (2017) (13)
- Sugar Sweetened Beverage Consumption among Adults with Gout or Type 2 Diabetes (2015) (13)
- Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements (2017) (13)
- Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review (2021) (12)
- Management of Gout in a Hospital Setting: A Lost Opportunity (2017) (12)
- Antibacterial Immunity to Staphylococcus pyogenes in Rabbits. (1961) (12)
- Paracrine upregulation of monocyte cyclooxygenase-2 by mediators produced by T lymphocytes: role of interleukin 17 and interferon-gamma. (2004) (12)
- Gout and the risk of COVID-19 diagnosis and death in the UK Biobank: a population-based study (2022) (12)
- The Māori and Pacific specific CREBRF variant and adult height (2019) (12)
- Gout and Organ Transplantation (2012) (12)
- Assessment of the Relationship Between Methotrexate Polyglutamates in Red Blood Cells and Clinical Response in Patients Commencing Methotrexate for Rheumatoid Arthritis (2014) (12)
- Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction (2021) (12)
- Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A (2016) (11)
- Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials (2021) (11)
- Population-specific factors associated with fractional excretion of uric acid (2019) (11)
- No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population. (2009) (11)
- Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell types. (2014) (11)
- Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout (2016) (11)
- Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999–2008 (2013) (11)
- Developing a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients. (2016) (11)
- Gout, rheumatoid arthritis and the risk of death from COVID-19: an analysis of the UK Biobank (2020) (10)
- How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose (2018) (10)
- Multi-energy photon-counting computed tomography versus other clinical imaging techniques for the identification of articular calcium crystal deposition. (2021) (10)
- A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis (2016) (10)
- Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. (2014) (10)
- Winds of change in imaging of calcium crystal deposition diseases. (2019) (10)
- Gout: Why compare the effectiveness of suboptimal gout management? (2015) (10)
- Rates of Joint Replacement Surgery in New Zealand, 1999–2015: A Comparison of Rheumatoid Arthritis and Osteoarthritis (2017) (9)
- Do Serum Urate–Associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK Biobank (2020) (9)
- Validation of a Definition for Flare in Patients with Established Gout (2017) (9)
- Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA (2007) (9)
- Ticlopidine as a Safe Alternative for Clopidogrel-associated Arthritis (2009) (9)
- Plasma oxypurinol as a measure of adherence in clinical trials (2017) (8)
- A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout (2015) (8)
- Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation (2018) (8)
- Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers (2020) (8)
- The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect (2021) (8)
- Tapering Biologic Therapy for Rheumatoid Arthritis: A Qualitative Study of Patient Perspectives (2019) (8)
- Urate-induced epigenetic modifications in myeloid cells (2021) (8)
- Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled Trial (2021) (8)
- Infliximab and adalimumab concentrations and anti‐drug antibodies in inflammatory bowel disease control using New Zealand assays (2019) (7)
- Wegener's granulomatosis: treatment and survival characteristics in a high‐prevalence southern hemisphere region (2012) (7)
- Plasma interleukin-23 and circulating IL-17A+IFNγ+ ex-Th17 cells predict opposing outcomes of anti-TNF therapy in rheumatoid arthritis (2022) (7)
- Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. (2017) (7)
- Greenshell™ Mussels: A Review of Veterinary Trials and Future Research Directions (2018) (7)
- ORIGINAL ARTICLE: Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long‐term methotrexate for rheumatoid arthritis (2010) (7)
- The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool (2018) (7)
- Exploring perceptions of a rheumatoid arthritis‐specific smoking cessation programme (2017) (7)
- Identification of a novel thiopurine S-methyltransferase allele (TPMT*37). (2014) (7)
- The contribution from interleukin-27 towards rheumatoid inflammation: insights from gene expression (2020) (7)
- A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria (2013) (7)
- Education Preferences of People With Gout: Exploring Differences Between Indigenous and Nonindigenous Peoples from Rural and Urban Locations (2018) (7)
- Improving gout education from patients' perspectives: a focus group study of Māori and Pākehā people with gout. (2018) (6)
- The challenges of managing gout in primary care: Results of a best-practice audit. (2019) (6)
- Treatment advances in gout. (2021) (6)
- Tapering biologic therapy for people with rheumatoid arthritis in remission: A review of patient perspectives and associated clinical evidence. (2019) (6)
- ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol. (2018) (6)
- Does genetic variability in aldehyde oxidase and molybdenum cofactor sulfurase predict nonresponse to allopurinol? (2010) (6)
- Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation (2018) (5)
- Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators (2018) (5)
- Multi-energy spectral photon-counting CT in crystal-related arthropathies: initial experience and diagnostic performance in vitro (2018) (5)
- Impact of COVID-19 on health research in New Zealand: a case study of a research-intensive campus (2021) (5)
- Flare Rate Thresholds for Patient Assessment of Disease Activity States in Gout (2020) (5)
- Aotearoa New Zealand Māori and Pacific Population-amplified Gout Risk Variants: CLNK Is a Separate Risk Gene at the SLC2A9 Locus (2021) (5)
- Pharmacogenetic considerations in the treatment of gout. (2015) (5)
- Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease (2022) (5)
- Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (2020) (5)
- Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial (2015) (5)
- Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis (2016) (5)
- Major unanswered questions in the clinical gout field (2017) (5)
- Urate testing in gout: why, when and how. (2015) (5)
- Does a Joint Count Calibration Exercise Make a Difference? Implications for Clinical Trials and Training (2012) (5)
- Serum urate levels and therapy in adults treated with long‐term dialysis: a retrospective cross‐sectional study (2019) (5)
- Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate! (2018) (4)
- Re: “Widespread prevalence of a CREBRF variant among Māori and Pacific children is associated with weight and height in early childhood” (2018) (4)
- Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review. (2021) (4)
- Soluble human leukocyte antigen: a diagnostic indicator of rheumatoid arthritis? (2006) (4)
- THU0493 Association of the Toll-Like Receptor 4 (TLR4) Gene with Gout (2014) (4)
- Clinical and genetic features of diuretic-associated gout: a case-control study. (2016) (4)
- Replication of Genetic Association of Peroxisome Proliferator-Activated Receptor Gamma-1B with Gout in a New Zealand Polynesian Sample Set (2017) (4)
- Discordant association of the CREBRF rs373863828 minor allele with increased body mass index and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa New Zealand (2017) (4)
- Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study (2017) (4)
- A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate. (2019) (4)
- Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group. (2021) (4)
- Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial (2021) (4)
- The Christchurch earthquake—providing a rheumatology service during a natural disaster (2012) (4)
- OP0158 Mitochondrial Genetic Variation and Susceptibility To Gout in Polynesians (2016) (4)
- What Are the Preferences of Patients With Rheumatoid Arthritis for Treatment Modification? A Scoping Review (2020) (3)
- Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis (2017) (3)
- Which factors predict discordance between a patient and physician on a gout flare? (2020) (3)
- Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration (2019) (3)
- Inequities in people with gout: a focus on Māori (Indigenous People) of Aotearoa New Zealand (2021) (3)
- Making the right thing the easy thing to do: strategies to improve outcomes in gout (2019) (3)
- Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women (2021) (3)
- Myeloperoxidase and oxidative stress in rheumatoid arthritis RHEUMATOLOGY (2012) (3)
- Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial (2022) (3)
- Critical appraisal of serum urate targets in the management of gout (2022) (3)
- Association of Crohn’s disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin (2018) (3)
- A natural "antibody" in rabbit serum producing a capular reaction with Staphylococcus pyogenes and related to immunity. (1967) (3)
- No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets. (2012) (3)
- What is remission in gout and how should we measure it? (2020) (3)
- Nortriptyline for pain in knee osteoarthritis in general practice: a double blind randomised controlled trial. (2021) (3)
- Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout (2022) (3)
- Dual-Energy Computed Tomography for Detection and Characterization of Monosodium Urate, Calcium Pyrophosphate, and Hydroxyapatite (2021) (3)
- Variability in Urate-lowering Therapy Prescribing: A Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Physician Survey (2020) (3)
- Pleiotropic effect of ABCG2 in gout: involvement in serum urate levels and progression from hyperuricemia to gout (2020) (3)
- Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practice (2021) (3)
- Analysis of association of DNASE2 promoter variation with rheumatoid arthritis in European Caucasians (2011) (2)
- Simplification of a pharmacokinetic model for red blood cell methotrexate disposition (2015) (2)
- Codevelopment of Patient Self‐Examination Methods and Joint Count Reporting for Rheumatoid Arthritis (2020) (2)
- Serum Urate as a Proposed Surrogate Outcome Measure in Gout Trials: From the OMERACT Working Group. (2021) (2)
- OP0172 EFFECT OF WEIGHT LOSS AND LIRAGLUTIDE ON SERUM URATE LEVELS AMONG OBESE KNEE OSTEOARTHRITIS PATIENTS: SECONDARY ANALYSIS OF A RANDOMISED CONTROLLED TRIAL (2020) (2)
- Comorbidities in Gout (2019) (2)
- Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study (2017) (2)
- Reassessing the cardiovascular safety of febuxostat: implications of the FAST study. (2021) (2)
- Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort (2022) (2)
- THU0464 A genome-wide association study of gout in people of european ancestry (2017) (2)
- HLA-B27 associated spondyloarthropathy, vasculitis, and amyloid enteropathy: response to infliximab. (2005) (2)
- Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial (2018) (2)
- Studies on O/R potential, pH and proteinase production in cultures of Streptococcus pyogenes, in relation to immunizing activity. (1953) (2)
- Multiplexed nanopore sequencing of HLA-B locus in Māori and Polynesian samples (2017) (2)
- Chapter 13 – Xanthine Oxidase Inhibitor Treatment of Hyperuricemia (2012) (2)
- Pulmonary haemorrhage in a 13‐year‐old girl: An unusual presentation of systemic lupus erythematosus (2008) (2)
- Pathophysiology and treatment of Paget’s disease of the bone.: Second Edition. Edited by John A. Kanis. Pp 304. London: Martin Dunitz Publishers, 1998. ISBN: 1-85317-463-7. £75.00. (1999) (1)
- Clinical Scientific Note (2005) (1)
- Weight gain with tumour necrosis factor-alpha inhibitors. (2005) (1)
- Mitochondrial genetic variation, copy number and susceptibility to gout in the New Zealand Polynesian (Māori and Pacific) population (2017) (1)
- Fructose malabsorption in people with and without gout: A case-control study. (2017) (1)
- Do Serum Urate–associated Genetic Variants Influence Gout Risk in People Taking Diuretics? Analysis of the UK Biobank (2020) (1)
- A genome-wide association study reveals association of the transferrin receptor locus with gout (2015) (1)
- SAT0530 Development of A Patient Reported Outcome Measure of Tophus Burden: the Tophus Impact Questionnaire (TIQ-20) (2014) (1)
- An allopurinol adherence tool using plasma oxypurinol concentrations. (2022) (1)
- Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial (2023) (1)
- Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (2020) (1)
- DEDMAN v. BRITISH BUILDING & ENGINEERING APPLIANCES LTD. (1974) (1)
- A genome-wide association analysis of 2,622,830 individuals reveals new pathogenic pathways in gout. (2022) (1)
- Giant cell arteritis: A population-based retrospective cohort study exploring incidence and clinical presentation in Canterbury, Aotearoa New Zealand (2022) (1)
- Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease (2018) (1)
- Formation of the Australian and New Zealand Vasculitis Society (ANZVASC) to improve the care of patients with vasculitis in Australia and New Zealand (2020) (1)
- A Polynesian-specific copy number variant encompassing the MHC Class I Polypeptide-related Sequence A (MICA) gene associates with gout. (2022) (1)
- Rheumatoid interstitial lung disease in Canterbury New Zealand: prevalence, risk factors and long-term outcomes—protocol for a population-based retrospective study (2022) (1)
- Colchicine twice daily for hand osteoarthritis: results from the double-blind, randomised, placebo-controlled color trial (2023) (0)
- A Clinically Significant Interaction Between Furosemide and Allopurinol: Potential Implications for Clinical Practice (2013) (0)
- OP0267 Serum urate as a surrogate endpoint for gout flares: results of a systematic review and meta-regression analysis of randomized trials (2017) (0)
- P17 Preference of Rheumatoid Arthritis Patients for Tapering Biologics: A Discrete Choice Experiment (2022) (0)
- Association of rs9939609 in FTO with BMI among Polynesian peoples living in Aotearoa New Zealand and other Pacific nations. (2023) (0)
- Clinical phenotype and complications of large vessel giant cell arteritis: a systematic review and meta-analysis. (2023) (0)
- Development of a radiographic scoring system for new bone formation in gout (2021) (0)
- Syddansk Universitet Using serum urate as a validated surrogate end point for flares in patients with gout protocol for a systematic review and meta-regression analysis (2016) (0)
- Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. (2023) (0)
- POS1124 IDENTIFYING POTENTIAL CLASSIFICATION CRITERIA FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD): RESULTS FROM THE INITIAL PHASES (2021) (0)
- FRI0252 Testing for a causal role of mitochondrial variation in the development of gout (2018) (0)
- Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (2020) (0)
- Activated CD90/Thy-1 fibroblasts co-express the Δ133p53β isoform and are associated with highly inflamed rheumatoid arthritis (2023) (0)
- Reply (2019) (0)
- Is repeat serum urate testing superior to a single test to predict incident gout over time? (2022) (0)
- Simplification of a pharmacokinetic model for red blood cell methotrexate disposition (2015) (0)
- Pre-term birth: effects on nephrogenesis in the human neonatal kidney (2008) (0)
- THU0366 Association of Chromosome 1Q32 with Ankylosing Spondylitis Is Independent of Bowel Symptoms and Faecal Calprotectin (2016) (0)
- Gout in Indigenous people: inequity and culturally appropriate management (2022) (0)
- New urate-lowering therapies in Aotearoa New Zealand: a response to Dr Lance Gravatt's letter on benzbromarone hepatotoxicity. (2013) (0)
- Association between Serum Urate As a Surrogate Endpoint and Flares in People with Gout: An Ecological Study Based on a Systematic Review of Trials and Open Label Extensions (2017) (0)
- Multivariate analysis of a missense variant in CREBRF reveals associations with measures of adiposity in people of Polynesian ancestries (2022) (0)
- List of Contributors (2019) (0)
- Allopurinol Dose Reductions Based on Creatinine Alert Redesign System. (2016) (0)
- Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis. (2023) (0)
- The contribution from interleukin-27 towards rheumatoid inflammation: insights from gene expression (2020) (0)
- Changes in Clinical Disease Activity Are Associated with Changes in the Total MRI Inflammation Score in Rheumatoid Arthritis Patients Who Are Escalating Therapy in a Treat-to-Target (T2T) Regimen (2017) (0)
- Management of gout - reply (2016) (0)
- Education and the Statistical Method in Business—With Special Reference to Railway Statistics (1939) (0)
- Comfort in Travel: Section II: By Rail (1939) (0)
- BUX v. SLOUGH METALS LTD (1973) (0)
- HILL v. C. A. PARSONS & CO. LTD. (1972) (0)
- PMS74 TAPERING BIOLOGIC? AN INSIGHT AND PERSPECTIVE OF RHEUMATOID ARTHRITIS PATIENTS (2019) (0)
- A Polynesian-specific copy number variant encompassing the MICA gene associates with gout (2022) (0)
- SMITH v. GEORGE WIMPEY & CO. LTD. AND JOHN LAING & SON LTD. (1972) (0)
- BENNETT v. CHEMICAL CONSTRUCTION (G.B.) LTD. (1972) (0)
- SMITH v. MANCHESTER CORPORATION (1974) (0)
- SMITH AND OTHERS v. CENTRAL ASBESTOS COMPANY LTD (1972) (0)
- SAYERS v. INTERNATIONAL DRILLING COMPANY N.V. (1971) (0)
- COMFORT IN TRAVEL. SECTION II-BY RAIL. PAPER PRESENTED AT JOINT MEETING, 10 MARCH, 1939. (ABRIDGED). (2015) (0)
- TARMAC ROADSTONE HOLDINGS LTD. v. PEACOCK AND OTHERS (1973) (0)
- HILLS v. NATIONAL COAL BOARD (1973) (0)
- STANLEY v. CONCENTRIC (PRESSED PRODUCTS) LTD (1972) (0)
- SARWAR v. SIMMONS & HAWKER LTD. (1972) (0)
- Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study (2017) (0)
- Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (2020) (0)
- A population-specific missense variant rs1597000001 in CETP promotes a favorable lipid profile and reduces CETP activity. (2021) (0)
- Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis (2021) (0)
- Experience with and clinical of utility of an in house ELISA based competitive binding assay to measure anti-TNF biologic concentration and anti-drug antibodies (2017) (0)
- Gout and coronavirus disease-19 (COVID-19): the risk of diagnosis and death in the UK Biobank (2021) (0)
- THU0539 Population-Specific Resequencing Reveals Association of The ABCC4/MRP4 Gene with Gout in New Zealand Māori and Pacific Men (2016) (0)
- No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat. (2019) (0)
- Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations (2021) (0)
- Comparative Effectiveness Of Pharmacological Interventions For Hand Osteoarthritis: A Systematic Review And Network Meta-Analysis Of Randomized Trials (2023) (0)
- Changes in the total MRI inflammation score are associated with changes in clinical disease activity in RA patients who are escalating therapy in a Treat-to-Target (T2T) regimen (2017) (0)
- SAT0045 Dna methylation of socs3 as a possible mechanism for persistent urate induced inflammation (2018) (0)
- The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics (2022) (0)
- 68 – Nutrition and Rheumatic Diseases (2013) (0)
- RAPID RECOMMENDATIONS Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline (2022) (0)
- The population pharmacokinetics of allopurinol and oxypurinol in patients with gout (2013) (0)
- Genome-Wide Association Study of Clinically-Ascertained Gout and Subtypes Identifies Multiple Susceptibility Loci Including Transporter Genes (2017) (0)
- Urate–lowering therapy: xanthine oxidase inhibitors (2013) (0)
- THU0492 Association Analysis of 18 Recently Discovered Serum Urate Loci with Gout (2014) (0)
- Population-specific Interaction of the TRIM46 / MUC1 Locus With Cigarette Smoking May Influence the Risk of Gout (2020) (0)
- Reply (2019) (0)
- Changes in tophus composition during urate-lowering therapy: a dual energy CT study. (2023) (0)
- Association of low-affinity FC gamma receptor 3B (FCGR3B) copy number variation with rheumatoid arthritis in Caucasian subjects (2009) (0)
- Medicinal Fatty Acids (2013) (0)
- AB1031 Anti-drug antibodies: assay performance in patients treated with ANTI-TNF biodrugs (2017) (0)
- A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles (2022) (0)
- A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis (2016) (0)
- Foods and rheumatologic diseases. (2014) (0)
- Comparison of two plasma urate assays in patients receiving vitamin C supplementation (2014) (0)
- A composite elisa for the rapid diagnosis of ANCA-associated vasculitis and ANTI-GBM mediated disease (2010) (0)
- Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout (2022) (0)
- Gout: Chapter 7, Comorbities in Gout, (2018) (0)
- Foods and Rheumatological diseases. (2009) (0)
- The Sex-Determining Region Y Box 6 Locus (2012) (0)
- Digital-PCR for gene expression: impact from inherent tissue RNA degradation (2017) (0)
- Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation (2022) (0)
- P89: HIGH FREQUENCY OF ANTI‐DRUG ANTIBODIES (ADA) DETECTED IN SERUM SAMPLES WITH LOW/ABSENT BIODRUG CONCENTRATIONS TAKEN FROM PATIENTS UNDERTAKING TREATMENT WITH ANTI‐TNF AGENTS (2017) (0)
- Review Gout and its comorbidities: implications for therapy (2012) (0)
- Self-management of gout using a mobile app (2022) (0)
- Chapter 68 – Nutrition and Rheumatic Diseases (2017) (0)
This paper list is powered by the following services:
Other Resources About Lisa Stamp
What Schools Are Affiliated With Lisa Stamp?
Lisa Stamp is affiliated with the following schools:
